Overview of Venous Thrombosis in Inflammatory Bowel Disease

Succinct Review of the New VTE Prevention and Management Guidelines

(2014) Amy West Pollak et al.   MAYO CLINIC PROCEEDINGS

Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability

(2014) Danuta Owczarek   WORLD JOURNAL OF GASTROENTEROLOGY

Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment

(2014) Alfredo Papa   WORLD JOURNAL OF GASTROENTEROLOGY

Reduced Plasma Fibrin Clot Permeability and Susceptibility to Lysis in Patients with Inflammatory Bowel Disease

(2013) Danuta Owczarek et al.   INFLAMMATORY BOWEL DISEASES

Venous and arterial disease in inflammatory bowel disease

(2013) Victoria P Tan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Calcineurin Inhibitors: 40 Years Later, Can't Live Without ...

(2013) J. R. Azzi et al.   JOURNAL OF IMMUNOLOGY

Overanticoagulation is associated with renal function decline

(2013) Jan Cornelis van Blijderveen et al.   JOURNAL OF NEPHROLOGY

Methotrexate: New Uses for an Old Drug

(2013) Philip J. Hashkes et al.   JOURNAL OF PEDIATRICS

Use of Glucocorticoids and Risk of Venous Thromboembolism

(2013) Sigrun A. Johannesdottir et al.   JAMA Internal Medicine

Venous Thromboembolism Prophylaxis

(2013) Bradley Champagne et al.   Clinics in Colon and Rectal Surgery

Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy

(2012) T. Bessissow et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevention of VTE in Nonsurgical Patients

(2012) Susan R. Kahn et al.   CHEST

Evidence-Based Management of Anticoagulant Therapy

(2012) Anne Holbrook et al.   CHEST

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

(2012) R. van der Pas et al.   CLINICAL ENDOCRINOLOGY

Physicians’ Perceptions of Risks and Practices in Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease

(2012) Justina J. Sam et al.   DIGESTIVE DISEASES AND SCIENCES

Thromboembolic events and anti‐tumor necrosis factor therapies

(2012) P.L. Masson   INTERNATIONAL IMMUNOPHARMACOLOGY

Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

(2012) Timothy A. Brighton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trials

(2012) José A. Nieto et al.   THROMBOSIS RESEARCH

The effects of calcineurin inhibitors on prostanoid synthesis: a randomized cross-over study in healthy humans

(2012) Lara Aygen Øzbay et al.   TRANSPLANT INTERNATIONAL

Inflammatory Bowel Disease and Thrombosis

(2012) Ahmet Tezel et al.   Turkish Journal of Hematology

Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases

(2011) A. Oussalah et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Venous Thromboembolism in Inflammatory Bowel Disease: An Epidemiological Review

(2011) Sanjay K Murthy et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: A case series and cohort study

(2011) L. A. Korswagen et al.   ARTHRITIS AND RHEUMATISM

Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: A cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials

(2011) Nilesh Chande et al.   INFLAMMATORY BOWEL DISEASES

Inflammatory bowel disease-associated thromboembolism: A systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis

(2011) James H. Tabibian et al.   INFLAMMATORY BOWEL DISEASES

Cerebral thrombosis in inflammatory bowel disease: A report of four cases

(2011) Fatma Houissa et al.   Journal of Crohns & Colitis

Thromboembolism in Inflammatory Bowel Disease: An Insidious Association Requiring a High Degree of Vigilance

(2011) Francesco Fabio et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)

(2011) Ola Dahl et al.   THROMBOSIS AND HAEMOSTASIS

Thrombosis and inflammatory bowel disease: A call for improved awareness and prevention

(2010) Naamah L. Zitomersky et al.   INFLAMMATORY BOWEL DISEASES

Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors

(2010) B. VAN ZAANE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

(2010) Michael Rud Lassen et al.   LANCET

Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study

(2010) Matthew J Grainge et al.   LANCET

Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

(2010) Michael Rud Lassen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Small intestinal bacterial overgrowth and warfarin dose requirement variability

(2010) Vittorio Giuliano et al.   THROMBOSIS RESEARCH

Inflammatory bowel disease

(2009) Hideo Yoshida et al.   INFLAMMATORY BOWEL DISEASES

Hypercoagulable State in Cushing’s Syndrome: A Systematic Review

(2009) Bregje Van Zaane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement

(2009) Michael Rud Lassen et al.   NEW ENGLAND JOURNAL OF MEDICINE

An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume

(2009) Osman Yüksel et al.   PLATELETS

Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients

(2008) Geoffrey C. Nguyen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism

(2008) Henry G Watson et al.   BLOOD REVIEWS

Thrombosis and inflammatory bowel disease-the role of genetic risk factors

(2008) Georgia Tsiolakidou et al.   WORLD JOURNAL OF GASTROENTEROLOGY